United States · FDA National Drug Code directory
duloxetine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49252-008_3fb45d3e-3fbc-8814-e063-6294a90a4a70
- Product NDC
- 49252-008
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- duloxetine
- Labeler
- Inventia Healthcare Limited.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20151205
- Source listing expiry
- 20261231
Source-listed ingredients
- DULOXETINE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-008-10) · 49252-008-10
- 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-008-11) · 49252-008-11
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-008-12) · 49252-008-12
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (49252-008-18) · 49252-008-18
- 100 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (49252-008-57) · 49252-008-57
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →